Connection
Samer Al Hadidi to Receptors, Antigen, T-Cell
This is a "connection" page, showing publications Samer Al Hadidi has written about Receptors, Antigen, T-Cell.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.647 |
|
|
|
-
Al Hadidi S, Heslop HE, Brenner MK, Suzuki M. Bispecific antibodies and autologous chimeric antigen receptor T?cell therapies for treatment of hematological malignancies. Mol Ther. 2024 Aug 07; 32(8):2444-2460.
Score: 0.233
-
Al Hadidi S, Cliff ERS. CARTIFAN-1: Concerning fatal adverse events with global use of chimeric antigen receptor-T-cell therapy in multiple myeloma. Eur J Cancer. 2023 03; 182:1-2.
Score: 0.211
-
Al Hadidi S, Zangari M, van Rhee F. Chimeric Antigen Receptor T-Cell Therapy in Multiple Myeloma-Challenges and Potential Solutions. JAMA Oncol. 2022 06 01; 8(6):823-824.
Score: 0.203